Effect of rivastigmine on scopolamine-induced memory impairment in rats

Citation
C. Bejar et al., Effect of rivastigmine on scopolamine-induced memory impairment in rats, EUR J PHARM, 383(3), 1999, pp. 231-240
Citations number
32
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF PHARMACOLOGY
ISSN journal
00142999 → ACNP
Volume
383
Issue
3
Year of publication
1999
Pages
231 - 240
Database
ISI
SICI code
0014-2999(19991103)383:3<231:EOROSM>2.0.ZU;2-N
Abstract
The effect of rivastigmine on memory impairments induced in rats by scopola mine (0.5 mg/kg) was assessed in the Morris water maze and passive avoidanc e tests and compared with that of tacrine (2.5-17.7 mg/kg). Rivastigmine, ( 0.5-2.5 mg/kg) inhibited cholinesterase in the cortex and hippocampus by 21 -60% and antagonised the deficits in working and reference memory. Tacrine (12.5 and 17.7 mg/kg) produced significantly less inhibition of cholinester ase in the hippocampus but more in the striatum than rivastigmine (0.75 and 1.5 mg/kg) and only antagonised the deficit in reference memory. Rivastigm ine (1.5 and 2.5 mg/kg) or tacrine (12.5 mg/kg), injected immediately after completion of the acquisition trial in the passive avoidance test, antagon ised the deficit induced by scopolamine (1 mg/kg) in memory retention. The inability of higher doses of the cholinesterase inhibitors to antagonise me mory deficits induced by scopolamine may be related to excessive cholinergi c stimulation in the central nervous system. (C) 1999 Elsevier Science B.V. All rights reserved.